PainReform Ltd
NASDAQ:PRFX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
PainReform Ltd
NASDAQ:PRFX
|
IL |
|
S
|
Sime Darby Plantation Bhd
KLSE:SIMEPLT
|
MY |
|
S
|
S Kijchai Enterprise PCL
SET:SKN
|
TH |
|
LATAM Airlines Group SA
SGO:LTM
|
CL |
|
HJ ShipBuilding & Construction Co Ltd
KRX:097230
|
KR |
|
C
|
CMG Pharmaceutical Co Ltd
KOSDAQ:058820
|
KR |
|
Zhuhai Bojay Electronics Co Ltd
SZSE:002975
|
CN |
|
R
|
Refine Group AB (publ)
STO:REFINE
|
SE |
|
Pulmatrix Inc
NASDAQ:PULM
|
US |
|
Cnb Community Bancorp Inc
OTC:CNBB
|
US |
|
H
|
Heineken NV
SWB:HNK1
|
NL |
|
Conduent Inc
NASDAQ:CNDT
|
US |
|
O
|
Organic Farma Zdrowia SA
WSE:ORG
|
PL |
|
S
|
Soosung Salvacion Co Ltd
KOSDAQ:084180
|
KR |
|
Lightspeed Commerce Inc
TSX:LSPD
|
CA |
|
S
|
SM Culture & Contents Co Ltd
KOSDAQ:048550
|
KR |
|
Scisparc Ltd
NASDAQ:SPRC
|
IL |
Balance Sheet
Balance Sheet Decomposition
PainReform Ltd
PainReform Ltd
Balance Sheet
PainReform Ltd
| Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
0
|
0
|
1
|
16
|
17
|
4
|
8
|
4
|
|
| Cash Equivalents |
0
|
0
|
1
|
16
|
17
|
4
|
8
|
4
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
2
|
2
|
8
|
2
|
0
|
|
| Total Current Assets |
0
|
0
|
1
|
18
|
19
|
12
|
10
|
4
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
0
-62%
|
1
+1 350%
|
18
+1 434%
|
19
+7%
|
12
-35%
|
10
-19%
|
5
-54%
|
|
| Liabilities | |||||||||
| Accounts Payable |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
1
|
1
|
2
|
2
|
|
| Short-Term Debt |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
5
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
0
|
6
|
1
|
1
|
1
|
2
|
2
|
|
| Long-Term Debt |
4
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
4
N/A
|
5
+18%
|
7
+50%
|
1
-83%
|
1
-16%
|
1
+32%
|
3
+105%
|
3
+0%
|
|
| Equity | |||||||||
| Common Stock |
7
|
7
|
7
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
10
|
11
|
12
|
16
|
24
|
33
|
42
|
56
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
33
|
42
|
43
|
49
|
58
|
|
| Total Equity |
4
N/A
|
4
-23%
|
6
-26%
|
17
N/A
|
18
+9%
|
11
-39%
|
7
-34%
|
2
-75%
|
|
| Total Liabilities & Equity |
0
N/A
|
0
-62%
|
1
+1 350%
|
18
+1 434%
|
19
+7%
|
12
-35%
|
10
-19%
|
5
-54%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
|